The effects of oral thylakoid intake on the metabolic, hormonal and inflammatory parameters in obese women with polycystic ovary syndrome under hypocaloric diet: A randomized double-blinded placebo controlled trial

Vice chancellor for research , Tabriz University of Medical Sciences,0 个研究点目标入组 48 人开始时间: 待定最近更新: 2021年2月22日

适应症

试验速览

暂无简介。

•All patients in our selected population were diagnosed with polycystic ovary syndrome according to Rotterdam diagnostic criteria with the diagnosis of the gynecologist.Having at least two of the three following symptoms:1-Abnormal menstrual cycles (oligomenorrhea, amenorrhea)2- Polycystic ovary in ultrasound3- Clinical signs of hyperandrogenism (Acne- Hirsutism) or biochemical symptoms of hyperandrogenism.
•Women aged 20-40 years
•Body Mass Index (BMI) range: 30-40 Kg/m2
•Moderate activity level
•Only OCP consumer (estrogen and progesterone combination pills). All participants will only receive OCP.
•Willingness to participate in the study

•Pregnancy(tendency to become pregnant) or lactation
•Having any illness that affecting the studied variables (such as liver disease, thyroid disease, cardiovascular disease, renal disease, gastrointestinal disease , Cushing's syndrome,adrenal hyperplasia, androgen-secreting tumors , hyperprolactinemia).
•Insulin infusion and intakes of blood pressure regulating drugs, statins and or drugs that affect insulin resistance (such as metformin), thiazolidinedione, anti androgens.
•Using of any vitamin and mineral supplements and or antioxidants or being under certain diets at least two months before the study.
•Any changes in the therapeutic protocol during the study

发起方

Vice chancellor for research , Tabriz University of Medical Sciences,